Changes in levels of expression of p53 and the product of the bcl-2 in lines of gastric cancer cells during cisplatin-lnduced apoptosis

European Surgical Research

Volumn 29, Issue 5, 1997, Pages 396-402

  Ikeguchi, Masahide ^a   Tatebe, S ^a   Kaibara, N ^a   Ito, H ^b  

^a Department of Surgery I ^*  (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bcl 2; Cisplatin; Gastric cancer cells; P53

Indexed keywords

ANTINEOPLASTIC AGENT; CELL PROTEIN; CISPLATIN; ONCOPROTEIN; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL CULTURE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; DRUG RESISTANCE; DRUG THERAPY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INCUBATION TIME; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APOPTOSIS; CISPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; STOMACH NEOPLASMS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030883546     PISSN: 0014312X     EISSN: 14219921     Source Type: Journal    
DOI: 10.1159/000129549     Document Type: Article

References (23)

1. Kerr JFR, Winlcrford CM, Harmon BV: Apoptosis: Its significance in cancer and cancer therapy. Cancer 1994:73:2013-2026.
2. Cece R, Barajon I, Tredici G: Cis-platin induces apoptosis in SI1-SY5Y human neuroblastoma cell line. Anticancer Res 1995; 15:777—782.
3. Huschtscha LI, Bartier WA, Ross CEA, Tattersall MHN: Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br J Cancer 1996:73:54-60.
4. Akagi Y, Ito K, Sawada S: Radiation-induced apoptosis and in Molt-4: A study of dosc-clTect relationships and their modification. Int J RadiatBiol 1993:64:47-56.
5. Ikeguchi M, Katano K, Tatcbe S, Oka A, Tsujitani S, Maeta M, Kai-bara N, Horikawa H, Ito H: Adria-mycin and cisplatin induce apoptosis in two lines of human gastric cancer cells (MKN-28 and HSC-39). Oncol Rep 1995;2:1027-1032.
6. Lowe SW, Bodis S, McClatchey A, Remington L, Rulcy HE, Fisher DE, Housman DE, Jacks T: p53 status and the efficacy of cancer therapy in vivo. Science 1994;266:807-810.
7. Zhan Q, Fan S, Bae I, Guillouf C, Liebcrmann DA, O'Connor FM, Fomace AJ Jr.,: Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 1994:9:3743—3751.
8. Korsmcver SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 1992:80:879-886.
9. Motoyama T, Hojo H, Watanabe H: Comparison of seven cell lines derived from human gastric carcinomas. Acta Pathol Jpn 1986:36:65—83.
10. Sekiguchi M, Sakakibara K, Fujii G: Establishment of cultured cell lines derived from a human gastric carcinoma. Jpn J Exp Med 1978:48:61—68.
11. Yagihara K, Sevama T, Tsumuraya M, Kamada N, Yokoro K: Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 1991:51:381-386.
12. Langley RE, Palayoor ST, Coleman CN, Bump EA: Radiation-induced apoptosis in F9 teraiocarcinoma cells. Int J Radial Biol 1994:65:605-610.
13. Kolber MA, Broschat KO, Landa-Gonzalez B: Cytochalasin B induces cellular DNA fragmentation. FA-SEBJ 1990:4:3021-3027.
14. Wyllie A HD, Kerr JF, Currie AR: Cell death: The significance of apoptosis. Int Rev Cytol 1980:68:251—306.
15. Yasui W, Sumiyoshi H, Hata J, Ka-meda T, Ochiai A, Ito H, Tahara E: Expression of epidermal grow th factor receptor in human gastric and colonic carcinoma. Cancer Res 1988:48:137-141.
16. Fairbanks G, Sleek TL, Wallach DFH: Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane. Biochemistry 1971;10:2606-2617.
17. Burditt LJ, Johnson MM, Johnson PJ, Williams R: Detection of hepatocellular carcinoma-specific aipha-fetoprotcin by isoelectric focusing. Cancer 1994;74:25-29.
18. Tahara E: Carcinogenesis and progression of human gastric cancer. Trans Soc Pathol Jpn 1992:81:21-49.
19. Kusumoto H, Machara Y, Yoshida M, Takahashi I, Anai H, Sugimachi K: Relationship between tumor his-topathologv and in vitro sensitivity to antitumor drugs in gastric cancer. Anticancer Drugs 1992:3:33—38.
20. Sinicrope FA, Ruan SB, Cleary KR, Stephens LC, Lee JJ, Levin B: bcl-2 and p53 oncoprotein expression during colorectal lumorigenesis. Cancer Res 1995:55:237-241.
21. Waldman T, Kinzlcr KW, Vogel-stein B: p21 is necessary for the p53-ntediated G arrest in human cancer cells. Cancer Res 1995:55:5187—5190.
22. Oltvai Z, Milliman C, Korsmeyer S: Bel-2 heterodimerizes in vivo with a conserved homolog, Bax. that accelerates programmed cell death. Cell 1993;74:609-619.
23. Figoli F, Galligioni E, Crivellarid D, Frustaci S, Talantini R, Sorio R, Saracchini S, Tumolo S, Lo Re G, Monfardini S: Evaluation of two consecutive regimens in advanced gastric cancer. Cancer Invest 1991: 9:257-262.